$HYFT News

MindWalk Holdings Reports Preclinical Dengue Data Supporting Computational Prediction Its HYFT Platform Generated Before Any Animal Was Immunized

The Biology Came First.

Jones Trading Initiates Coverage On MindWalk Holdings with Buy Rating, Announces Price Target of $5

MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts

MindWalk Holdings Corp. Q3 2026 Earnings Call Summary

MindWalk (HYFT) Q3 2026 Earnings Call Transcript

MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates

MindWalk Holdings Corp. (NASDAQ:HYFT) Reports Mixed Q3 2026 Results Amid Strategic Pivot

MindWalk Holdings Corp. 2026 Q3 - Results - Earnings Call Presentation

MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript

MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results

MindWalk Holdings Q3 EPS $(0.06) Misses $(0.04) Estimate, Sales $2.997M Miss $3.500M Estimate

MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era

MindWalk Holdings shares are trading higher after the company announced B Cell Llama.

MindWalk Holdings shares are trading higher after the company announced B Cell Llama.

MindWalk Launches B Cell Llama AI Nanobody Discovery Platform Following Peer-Reviewed Study Published In ACS Biomacromolecules Showing Enhanced Potency, Cross-Variant Activity, And Potential Immune-Priming Effects For Next-Generation Antibody And Cell Therapies

MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026

MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics

MindWalk Applies HYFT Technology To Uncover Functional Adjacency Beyond Sequence Similarity In AI-Accelerated Drug Discovery

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease